Trevi Therapeutics Announces Third Quarter 2020 Financial Results and Business Update
PRISM Trial of Haduvio™ for Severe Pruritus in Patients with Prurigo Nodularis Exceeds Halfway Enrollment…
Year: 2020
PDS Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update
FLORHAM PARK, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Salarius Pharmaceuticals Reports Business Highlights and Third Quarter 2020 Financial Results
Conference Call and Live Audio Webcast Scheduled for Today, November 11, 2020, at 4:30 p.m….
Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results
– Conference Call Scheduled November 11, 2020 at 4:30 p.m. ET – BERKELEY HEIGHTS, N.J.,…
OpGen Reports Third Quarter 2020 Financial Results and Provides Business Update
OpGen takes strategic steps to expand the Unyvero platform and product pipeline, to focus on…
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology…
Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting
Data shows CPI-006 provided enhanced and prolonged polyclonal humoral immunity to SARS–CoV–2 Plans to initiate…
CytomX Therapeutics to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Ascendis Pharma A/S Reports Third Quarter 2020 Financial Results
– European Medicines Agency (EMA) validated the Marketing Authorisation Application (MAA) for TransConTM hGH (lonapegsomatropin) in…
Spectral Announces Third Quarter Results
Corporate Highlights: Dialco’s DIMI receives FDA 510(k) clearance for use in hospital and clinical settings…
Chalice Farms to Honor Veterans Day with Increased Military Discount
PORTLAND, Ore., Nov. 11, 2020 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden…
Telo Genomics Announces the Final Assignment of Patents on Hematological Cancers, Liquid Biopsy and Alzheimer’s Disease
TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Telo Genomics Corp. (TSX-V: TELO) (the “Company” or…
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
Scheduled to Reconvene on November 25, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov….
J. Knipper and Company, Inc. Finalizes Acquisition of Eagle Pharmacy to Expand Company’s Pharmacy Programs, Scale and Automation Capabilities
One of the Largest Suppliers of Pharmaceutical Marketing Solutions and Specialty Pharmacy Services in the…
Shattuck Labs Announces Preclinical Proof of Concept Study on Gamma Delta T Cell Engager, GADLEN™, Platform at SITC 2020
AUSTIN, TX and DURHAM, NC, Nov. 11, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin
TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed wet AMD Treatment Landscape and ONS-5010/LYTENAVA™
Dr. Rahhal, a leading retinal clinician, offered insight on wet AMD treatment and the potential…
Mersana Therapeutics Reports Preclinical Data from Immunosynthen STING-Agonist ADC Platform and Pipeline
Immunosynthen ADCs activate the STING pathway in both tumor-resident immune cells and in the tumor…
Sorrento Announces IND Filing for COVI-DROPS, an Intranasal Formulation of a High Potency Neutralizing Antibody Against SARS-CoV-2
IND filing today for STI-2099 (COVI-DROPS™) for a phase 1 safety and pharmacokinetic study in…
SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020
Late breaking poster demonstrates SO-C101 was well tolerated to date with no dose-limiting toxicities Confirmed…